All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Liraglutide 1.2mg: Switching To

How to switch to liraglutide 1.2mg. Covers the standard titration from 0.6mg, switching from Victoza to Saxenda dosing, and practical tips for the dose...

By FormBlends Editorial Research||
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

How to switch to liraglutide 1.2mg. Covers the standard titration from 0.6mg, switching from Victoza to Saxenda dosing, and practical tips for the dose increase.

Switching to liraglutide 1.2mg is the first dose increase in the titration schedule, typically done after one week at 0.6mg. The switch involves simply dialing the pen to 1.2mg on your next injection instead of 0.6mg. No new pens, prescriptions, or special preparation required. The same multi-dose pen you have been using for 0.6mg delivers 1.2mg by adjusting the dose selector. This straightforward transition is how millions of patients have begun their liraglutide process.

Standard Titration: 0.6mg to 1.2mg

The move from 0.6mg to 1.2mg follows the standard titration schedule. After seven days at 0.6mg, you increase to 1.2mg on day 8. The mechanics are simple:

  • Using the same pen, dial to the 1.2mg marking instead of 0.6mg
  • Inject at the same time, same site rotation pattern
  • No need to change anything about your routine except the dose dial

Readiness checklist before switching:

  • Completed at least 7 days at 0.6mg
  • Nausea has resolved or is manageable
  • No concerning symptoms to report
  • Daily injection routine is established
  • Sufficient pen supply to continue at the higher dose

Liraglutide 1.2mg what to expect

Switching from Victoza 1.2mg to Saxenda

Patients already on Victoza (liraglutide 1.2mg for type 2 diabetes) who want to switch to Saxenda (liraglutide 3.0mg for weight management) have an advantage: they're already at the 1.2mg level and can skip the 0.6mg introductory week.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Liraglutide 1.2mg: Switching To

Typical transition plan:

  • Stop Victoza 1.2mg
  • Start Saxenda at 1.2mg (same dose, different brand and indication)
  • Continue titrating up: 1.8mg after one week, 2.4mg the following week, then 3.0mg
  • compounded formulations of the active ingredient (liraglutide) is in both products, so no cross-medication adjustment is needed

Insurance note: Victoza and Saxenda are different products with different NDC codes and coverage. Switching from one to the other requires a new prescription and may require a new prior authorization. Plan ahead. Contact provider for current pricing

Switching from Other GLP-1 Medications to Liraglutide 1.2mg

If you're switching from semaglutide or tirzepatide to liraglutide, you should start at 0.6mg and titrate through the full schedule, reaching 1.2mg in week 2. Here is what to expect at the 1.2mg transition point:

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
  • From semaglutide: You may notice that liraglutide 1.2mg provides less appetite suppression than your previous semaglutide dose. This is expected. Liraglutide is generally less potent than semaglutide for weight loss. The effect builds as you titrate to 3.0mg.
  • From tirzepatide: The transition may feel like a significant step backward in appetite control, since tirzepatide activates both GIP and GLP-1 receptors. Again, this improves at higher liraglutide doses, though 3.0mg liraglutide is generally less effective than tirzepatide at therapeutic doses.

Liraglutide 0.6mg switching to

Pen Supply Considerations

At 1.2mg daily, you use twice as much medication per day as you did at 0.6mg. This affects how long each pen lasts:

Daily Dose Days Per Pen (Saxenda 18mg pen)
0.6mg ~30 days
1.2mg ~15 days
1.8mg ~10 days
2.4mg ~7.5 days
3.0mg ~6 days

Make sure you have enough pens to cover the titration without a gap. A standard Saxenda prescription comes with 5 pens (90mg total), which lasts approximately 30 days at the full 3.0mg dose. During titration, you use less medication daily, so your initial supply stretches further.

Frequently Asked Questions

Do I need a new prescription to switch from 0.6mg to 1.2mg?
No. The Saxenda prescription covers the full titration from 0.6mg to 3.0mg. The pen is multi-dose, and you adjust the dose dial yourself. No pharmacy visit or new prescription needed for dose increases.
What if I am not ready to increase after one week at 0.6mg?
Staying at 0.6mg for a second week is perfectly acceptable. Inform your prescriber and move to 1.2mg when you feel ready. The titration timeline is flexible. liraglutide 0.6mg how long to stay on
Should I inject 1.2mg at the same time I was doing 0.6mg?
Yes. Maintaining the same injection time provides consistency and makes the habit automatic. There's no clinical reason to change your timing when increasing the dose.
Can I go directly from 0.6mg to 1.8mg and skip 1.2mg?
This isn't recommended. The jump from 0.6mg to 1.8mg triples the dose in one step and significantly increases GI side effect risk. The one-week stay at 1.2mg helps your body adapt to the intermediate level. Follow the prescribed titration.

This article is for informational purposes only and doesn't constitute medical advice. Follow your prescriber's titration guidance for the best results.

Contact provider for current pricing Contact provider for current pricing

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Liraglutide 1.2mg: Switching To custom 2026 header image for GLP-1 Weight Loss
Custom header image for Liraglutide 1.2mg: Switching To, GLP-1 Weight Loss, and better treatment decision-making.

Research Snapshot

Research guide
Page type
Research guide
Page metadata
Page updated
2026-04-01
Page metadata
Retatrutide official website
Official source
Saxenda official website
Official source
Semaglutide official website
Official source
Tirzepatide official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-04-01.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Related treatment context

Liraglutide 1.2mg: Switching To research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.